alkenes has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Happ, AM; Jakubowski, JA; Layman, N; Mais, DE; Takeuchi, K; Utterback, BG; Wyss, VL | 1 |
| Jalil, J; Jantan, I; Jasamai, M; Saadawi, S | 1 |
2 other study(ies) available for alkenes and thromboxane b2
| Article | Year |
|---|---|
Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition--I. Synthesis, structure-activity relationship, and evaluation of substituted omega-phenyl-omega-(3-pyridyl)alkenoic acids.
Topics: 6-Ketoprostaglandin F1 alpha; Alkenes; Animals; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane B2; Thromboxane-A Synthase | 1994 |
Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin E₂ and Thromboxane B₂ production and platelet activating factor receptor binding.
Topics: Alkenes; Animals; Annonaceae; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flavonoids; Humans; Inhibitory Concentration 50; Plant Extracts; Plant Leaves; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polycyclic Aromatic Hydrocarbons; Rabbits; Radioimmunoassay; Receptors, G-Protein-Coupled; Thromboxane B2 | 2012 |